Literature DB >> 30328224

Modelling mood disorders: An ACE solution?

Gin S Malhi1,2,3,4, Lauren Irwin1,2,3,4, Amber Hamilton1,2,3,4, Grace Morris1,2,3,4, Philip Boyce1,5, Roger Mulder1,6, Richard J Porter1,6.   

Abstract

OBJECTIVES: The treatment of mood disorders remains sub-optimal. A major reason for this is our lack of understanding of the underlying pathophysiology of depression and bipolar disorder. A core problem is the lack of specificity of our current diagnoses. This paper discusses the history of this problem and posits a solution in the form of a more sophisticated model.
METHOD: The authors review the notable historical works that laid the foundations of mood disorder nosology; discuss the more recent influences that shaped modern diagnoses; and examine the evidence that mood disorders are characterised by multidimensional and longitudinal symptom profiles.
RESULTS: The ACE model considers mood disorders as a combination of symptoms across three domains: Activity, Cognition, and Emotion; that vary over time. This multidimensional and longitudinal perspective is consistent with the prevalence of complex clinical presentations, such as mixed states, and highlights the importance of recurrence in mood disorders.
CONCLUSIONS: The ACE model encourages researchers to characterise patients from a number of equally important perspectives and, by doing so, add specificity to the treatment of mood disorders.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bipolar disorder; major depressive disorder; mixed states; modelling; mood disorders

Mesh:

Year:  2018        PMID: 30328224     DOI: 10.1111/bdi.12700

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  6 in total

1.  Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity-Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patients.

Authors:  Ludovico Mineo; Alessandro Rodolico; Giorgio Alfredo Spedicato; Andrea Aguglia; Simone Bolognesi; Carmen Concerto; Alessandro Cuomo; Arianna Goracci; Giuseppe Maina; Andrea Fagiolini; Mario Amore; Eugenio Aguglia
Journal:  Eur Psychiatry       Date:  2022-05-31       Impact factor: 7.156

Review 2.  Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection.

Authors:  Alfredo B Cuéllar-Barboza; Susan L McElroy; Marin Veldic; Balwinder Singh; Simon Kung; Francisco Romo-Nava; Nicolas A Nunez; Alejandra Cabello-Arreola; Brandon J Coombes; Miguel Prieto; Hannah K Betcher; Katherine M Moore; Stacey J Winham; Joanna M Biernacka; Mark A Frye
Journal:  Int J Bipolar Disord       Date:  2020-07-04

Review 3.  The existential crisis of bipolar II disorder.

Authors:  Michael Gitlin; Gin S Malhi
Journal:  Int J Bipolar Disord       Date:  2020-01-28

Review 4.  The structure of mania: An overview of factorial analysis studies.

Authors:  Diego J Martino; Marina P Valerio; Gordon Parker
Journal:  Eur Psychiatry       Date:  2020-02-10       Impact factor: 5.361

5.  Prepubertal bipolar disorder: a diagnostic quandary?

Authors:  Gin S Malhi; Erica Bell
Journal:  Int J Bipolar Disord       Date:  2020-04-20

Review 6.  Mixed Depression: A Mini-Review to Guide Clinical Practice and Future Research Developments.

Authors:  Antimo Natale; Ludovico Mineo; Laura Fusar-Poli; Andrea Aguglia; Alessandro Rodolico; Massimo Tusconi; Andrea Amerio; Gianluca Serafini; Mario Amore; Eugenio Aguglia
Journal:  Brain Sci       Date:  2022-01-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.